For the next steps, ECOG-ACRIN researchers are planning another trial to determine how further to optimize taxane therapy for Black patients with breast cancer. They will also build on the current ...

The Grafo movable acoustic whiteboard from Impact Acoustic offers flexibility of use. Acting as a collaboration tool or temporary separation in open-plan spaces while improving the acoustic ...

Lead investigator Kristen R. Spencer, DO, MPH, a medical oncologist at New York University's Langone Perlmutter Cancer Center and chair of the ECOG-ACRIN Genomics Subcommittee. Another ECOG-ACRIN ...

Ballinger presented findings from ECOG-ACRIN EAZ171, a phase II trial that exclusively enrolled Black women with stage I-III breast cancer (N=240) already planning to receive (neo)adjuvant taxane ...

The CompassHER2 pCR Trial protocol has been amended to include the evaluation of the HER2DX ® genomic test as a key secondary endpoint. HER2DX ® pCR-score and HER2DX ® risk-score will be ...

If you build it, they will come: Success of the EROS (Engendering Reproductive Health Within Oncologic Survivorship)—ECOG-ACRIN E1Q11 in recruitment of minority patients. This is an ASCO Meeting ...

Dr. Shannon Westin and her guest, Dr. Bryan Schneider discuss the article “ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-induced Peripheral Neuropathy in Black Women ...